Posted On: 04/10/2014 12:16:44 PM
Post# of 36729
With SEC on warpath targeting sector players, it would certainly be prudent to delay or drop the planned merger which will draw intense scrutiny to both tickers (AEGY/SKTO) at the worst possible time.
With merger plans afoot and filings due for regulators, a $300,000 saturation campaign springs up recruiting a a small army of pump-and-dump touts working 77 promotional newsletters not including a cadre of touts employing bulk email. Walking a frayed tightrope high above a concrete parking lot without permission would carry less risk of drawing ire from authorities.
In a merger involving participants known to the SEC for disreputable conduct and with AEGY being a partner of limitless dilution, any sensible managers would delay walking SKTO into SEC hoops of fire, if for no other reason than to protect the crown jewels of Berkeley Bio.
With merger plans afoot and filings due for regulators, a $300,000 saturation campaign springs up recruiting a a small army of pump-and-dump touts working 77 promotional newsletters not including a cadre of touts employing bulk email. Walking a frayed tightrope high above a concrete parking lot without permission would carry less risk of drawing ire from authorities.
In a merger involving participants known to the SEC for disreputable conduct and with AEGY being a partner of limitless dilution, any sensible managers would delay walking SKTO into SEC hoops of fire, if for no other reason than to protect the crown jewels of Berkeley Bio.
(0)
(0)
